Compare MDXG & LGIH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDXG | LGIH |
|---|---|---|
| Founded | 2006 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Homebuilding |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 984.3M |
| IPO Year | 2007 | 2013 |
| Metric | MDXG | LGIH |
|---|---|---|
| Price | $4.13 | $34.38 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 5 |
| Target Price | $10.00 | ★ $75.90 |
| AVG Volume (30 Days) | ★ 780.8K | 418.7K |
| Earning Date | 04-29-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 14.29 | N/A |
| EPS | 0.32 | ★ 3.12 |
| Revenue | $418,630,000.00 | ★ $1,705,504,000.00 |
| Revenue This Year | N/A | $6.01 |
| Revenue Next Year | $13.14 | $14.33 |
| P/E Ratio | $13.03 | ★ $11.89 |
| Revenue Growth | ★ 19.99 | N/A |
| 52 Week Low | $4.12 | $36.13 |
| 52 Week High | $8.12 | $72.86 |
| Indicator | MDXG | LGIH |
|---|---|---|
| Relative Strength Index (RSI) | 24.51 | 17.60 |
| Support Level | N/A | N/A |
| Resistance Level | $5.38 | $55.70 |
| Average True Range (ATR) | 0.16 | 2.02 |
| MACD | -0.02 | -1.01 |
| Stochastic Oscillator | 13.29 | 3.26 |
MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.
LGI Homes Inc is engaged in the design, construction, and sale of new homes in markets. The company's current product offerings include entry-level homes, including both detached homes and townhomes, and move-up homes sold, which are sold under the LGI Homes brand, and luxury series homes, which are sold under the Terrata Homes brand. It offers a set number of floor plans in each community with features that include upgrades, such as granite countertops, appliances, and ceramic tile flooring. The company has seven operating segments: West, Northwest, Central, Midwest, Florida, Southeast, and Mid-Atlantic. The majority of the revenue is generated from the Central division segment.